APA (7th ed.) Citation

R, R., N, W., C, C., M, Y., B, L., Y, Y., . . . Y, H. (2026). Integrated pharmacology and experimental validation reveals potential multiple mechanisms of the neutrophil elastase inhibitor sivelestat in attenuating myocarditis. Frontiers in pharmacology, 17, 1695352. https://doi.org/10.3389/fphar.2026.1695352

Chicago Style (17th ed.) Citation

R, Ren, et al. "Integrated Pharmacology and Experimental Validation Reveals Potential Multiple Mechanisms of the Neutrophil Elastase Inhibitor Sivelestat in Attenuating Myocarditis." Frontiers in Pharmacology 17 (2026): 1695352. https://doi.org/10.3389/fphar.2026.1695352.

MLA (9th ed.) Citation

R, Ren, et al. "Integrated Pharmacology and Experimental Validation Reveals Potential Multiple Mechanisms of the Neutrophil Elastase Inhibitor Sivelestat in Attenuating Myocarditis." Frontiers in Pharmacology, vol. 17, 2026, p. 1695352, https://doi.org/10.3389/fphar.2026.1695352.